Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $20.2900 (-1.79%) ($19.9300 - $20.9900) on Tue. Jan. 29, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.73% (three month average) | RSI | 32 | Latest Price | $20.2900(-1.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -10.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(61%) XBI(60%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.865% in a week (0% probabilities). VXX(-13%) VIXM(-9%) XHB(-4%) TLT(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.865% (StdDev 5.73%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
Resistance Level | $23.71 | 5 Day Moving Average | $20.77(-2.31%) | 10 Day Moving Average | $22.83(-11.13%) | 20 Day Moving Average | $23.71(-14.42%) | To recent high | -36.2% | To recent low | 11.5% | Market Cap | $1.26b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |